Post market surveillance in the german medical device sector – current state and future perspectives
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2017.06.005
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Schreyögg, Jonas & Bäumler, Michael & Busse, Reinhard, 2009. "Balancing adoption and affordability of medical devices in Europe," Health Policy, Elsevier, vol. 92(2-3), pages 218-224, October.
- Niederländer, Charlotte & Wahlster, Philip & Kriza, Christine & Kolominsky-Rabas, Peter, 2013. "Registries of implantable medical devices in Europe," Health Policy, Elsevier, vol. 113(1), pages 20-37.
- Fuchs, Sabine & Olberg, Britta & Panteli, Dimitra & Perleth, Matthias & Busse, Reinhard, 2017. "HTA of medical devices: Challenges and ideas for the future from a European perspective," Health Policy, Elsevier, vol. 121(3), pages 215-229.
- Perleth, Matthias & Busse, Reinhard & Schwartz, Friedrich Wilhelm, 1999. "Regulation of health-related technologies in Germany," Health Policy, Elsevier, vol. 46(2), pages 105-126, January.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Shatrov, Kosta & Blankart, Carl Rudolf, 2022. "After the four-year transition period: Is the European Union's Medical Device Regulation of 2017 likely to achieve its main goals?," Health Policy, Elsevier, vol. 126(12), pages 1233-1240.
- Claus Zippel & Sabine Bohnet-Joschko, 2021. "Rise of Clinical Studies in the Field of Machine Learning: A Review of Data Registered in ClinicalTrials.gov," IJERPH, MDPI, vol. 18(10), pages 1-14, May.
- Choi, Soo Jeong & Nam, Ki Chang & Choi, Sooin & Kim, Jin Kuk & Lee, You Kyoung & Kwon, Bum Sun, 2021. "The establishment of the Korean medical device safety information monitoring center: Reviewing ten years of experience," Health Policy, Elsevier, vol. 125(7), pages 941-946.
- Semjonova Nadezhda, 2020. "Economic Tendencies of the European and Latvian Medical Device Market," Economics and Business, Sciendo, vol. 34(1), pages 297-310, February.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Fuchs, Sabine & Olberg, Britta & Perleth, Matthias & Busse, Reinhard & Panteli, Dimitra, 2019. "Testing a new taxonomic model for the assessment of medical devices: Is it plausible and applicable? Insights from HTA reports and interviews with HTA institutions in Europe," Health Policy, Elsevier, vol. 123(2), pages 173-181.
- Lübbeke, A. & Silman, A.J. & Barea, C. & Prieto-Alhambra, D. & Carr, A.J., 2018. "Mapping existing hip and knee replacement registries in Europe," Health Policy, Elsevier, vol. 122(5), pages 548-557.
- Beck, ACC & Retèl, VP & Bhairosing, PA & van den Brekel, MWM & van Harten, WH, 2019. "Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review," Health Policy, Elsevier, vol. 123(12), pages 1185-1198.
- Martelli, Nicolas & van den Brink, Hélène, 2014. "Special funding schemes for innovative medical devices in French hospitals: The pros and cons of two different approaches," Health Policy, Elsevier, vol. 117(1), pages 1-5.
- Maximilian H. M. Hatz & Jonas Schreyögg & Aleksandra Torbica & Giuseppe Boriani & Carl R. B. Blankart, 2017. "Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 124-144, February.
- Kastanioti, Catherine & Kontodimopoulos, Nick & Stasinopoulos, Dionysis & Kapetaneas, Nikolaos & Polyzos, Nikolaos, 2013. "Public procurement of health technologies in Greece in an era of economic crisis," Health Policy, Elsevier, vol. 109(1), pages 7-13.
- Philip Klein & Hedwig Blommestein & Maiwenn Al & Benedetta Pongiglione & Aleksandra Torbica & Saskia de Groot, 2022. "Real‐world evidence in health technology assessment of high‐risk medical devices: Fit for purpose?," Health Economics, John Wiley & Sons, Ltd., vol. 31(S1), pages 10-24, September.
- Pedro Parreira & Liliana B. Sousa & Inês A. Marques & Paulo Santos-Costa & Sara Cortez & Filipa Carneiro & Arménio Cruz & Anabela Salgueiro-Oliveira, 2020. "Usability Assessment of an Innovative Device in Infusion Therapy: A Mix-Method Approach Study," IJERPH, MDPI, vol. 17(22), pages 1-13, November.
- Schreyögg, Jonas & Henke, Klaus-Dirk & Busse, Reinhard, 2004. "Managing pharmaceutical regulation in Germany: Overview and economic assessment," Discussion Papers 2004/6, Technische Universität Berlin, School of Economics and Management.
- Levaggi, Rosella & Moretto, Michele & Pertile, Paolo, 2014. "Two-part payments for the reimbursement of investments in health technologies," Health Policy, Elsevier, vol. 115(2), pages 230-236.
- Rosanna Tarricone & Aleksandra Torbica & Michael Drummond, 2017. "Challenges in the Assessment of Medical Devices: The MedtecHTA Project," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 5-12, February.
- Sandor Kovács & Zoltán Kaló & Rita Daubner‐Bendes & Katarzyna Kolasa & Rok Hren & Tomas Tesar & Vivian Reckers‐Droog & Werner Brouwer & Carlo Federici & Mike Drummond & Antal Tamás Zemplényi, 2022. "Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries," Health Economics, John Wiley & Sons, Ltd., vol. 31(S1), pages 195-206, September.
- Rachet-Jacquet, Laurie & Toulemon, Léa & Rochaix, Lise, 2021.
"Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List,"
Health Policy, Elsevier, vol. 125(7), pages 923-929.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Post-Print halshs-03238834, HAL.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," Institut des Politiques Publiques halshs-03238834, HAL.
- Laurie Rachet-Jacquet & Léa Toulemon & Lise Rochaix, 2021. "Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List," PSE-Ecole d'économie de Paris (Postprint) halshs-03238834, HAL.
- Deo, Sarang & Tyagi, Hanu & Chatterjee, Chirantan & Molakapuri, Himasagar, 2020. "Did India's price control policy for coronary stents create unintended consequences?," Social Science & Medicine, Elsevier, vol. 246(C).
- Walshe, Ronald & Schmitz, Norbert & Diehl, Volker, 1999. "Can corporatization contribute to quality assurance and cost control in the German hospital sector?: A pilot project for stem cell transplantation," Health Policy, Elsevier, vol. 48(3), pages 207-218, August.
- Sorenson, Corinna & Kanavos, Panos, 2011. "Medical technology procurement in Europe: A cross-country comparison of current practice and policy," Health Policy, Elsevier, vol. 100(1), pages 43-50, April.
- Rowan Iskandar & Carlo Federici & Cassandra Berns & Carl Rudolf Blankart, 2022. "An approach to quantify parameter uncertainty in early assessment of novel health technologies," Health Economics, John Wiley & Sons, Ltd., vol. 31(S1), pages 116-134, September.
- Henschke, Cornelia, 2012. "Provision and financing of assistive technology devices in Germany: A bureaucratic odyssey? The case of amyotrophic lateral sclerosis and Duchenne muscular dystrophy," Health Policy, Elsevier, vol. 105(2), pages 176-184.
- Fischer, Katharina E. & Rogowski, Wolf H. & Leidl, Reiner & Stollenwerk, Björn, 2013. "Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis," Health Policy, Elsevier, vol. 112(3), pages 187-196.
- Franz Tödtling & Tanja Sinozic & Alexander Auer, 2016.
"Knowledge bases, multi-scale interaction and transformation of the Vienna medical cluster,"
SRE-Disc
sre-disc-2016_03, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
- Tödtling, Franz & Sinozic, Tanja & Auer, Alexander, 2016. "Knowledge bases, multi-scale interaction and transformation of the Vienna medical cluster," SRE-Discussion Papers 2016/03, WU Vienna University of Economics and Business.
More about this item
Keywords
Medical devices; Post marketing; Product surveillance; European Union; Medical device regulation (MDR); In vitro diagnostic regulations (IVDR);All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:121:y:2017:i:8:p:880-886. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.